Genome-wide identification of high-affinity estrogen response elements in human and mouse

Molecular Endocrinology

Volumn 18, Issue 6, 2004, Pages 1411-1427

  Bourdeau, Véronique ^a,b   Deschênes, Julie ^a   Métivier, Raphaël ^c,d   Nagai, Yoshihiko ^b   Nguyen, Denis ^a   Bretschneider, Nancy ^c   Gannon, Frank ^c   White, John H ^b   Mader, Sylvie ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^d Unité Mixte de Recherche 6026   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; BREAST CANCER; CANCER CELL CULTURE; CHROMATIN STRUCTURE; ESTROGEN RESPONSIVE ELEMENT; GENE IDENTIFICATION; GENOME; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; START CODON;

ALGORITHMS; ANIMALS; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; COMPUTATIONAL BIOLOGY; DATABASES; ESTROGENS; GENOME; GENOME, HUMAN; HELA CELLS; HUMANS; MICE; RESPONSE ELEMENTS; RNA, MESSENGER; STATISTICS; TRANSCRIPTION, GENETIC;

ANIMALIA; RODENTIA;

EID: 2542463869     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2003-0441     Document Type: Article

References (134)

1. Couse JF, Korach KS 1999 Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20:358-417
2. McEwen BS, Alves SE 1999 Estrogen actions in the central nervous system. Endocr Rev 20:279-307
3. Jordan VC 2001 Estrogen, selective estrogen receptor modulation, and coronary heart disease: something or nothing. J Natl Cancer Inst 93:2-4
4. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, Gustafsson JA 2001 Mechanisms of estrogen action. Physiol Rev 81:1535-1565
5. Green S, Chambon P 1988 Nuclear receptors enhance our understanding of transcription regulation. Trends Genet 4:309-314
6. Beato M, Herrlich P, Schütz G 1995 Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857
7. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM 1995 The nuclear receptor family: the second decade. Cell 83:835-839
8. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ 2001 Nuclear receptors and lipid physiology: opening the X-files. Science 294:1866-1870
9. Robinson-Rechavi M, Escriva Garcia H, Laudet V 2003 The nuclear receptor superfamily. J Cell Sci 116:585-586
10. Krust A, Green S, Argos P, Kumar V, Walter P, Bornert JM, Chambon P 1986 The chicken oestrogen receptor sequence: homology with v-erbA and the human oestrogen and glucocorticoid receptors. EMBO J 5:891-897
11. Mader S, Chambon P, White JH 1993 Defining a minimal estrogen receptor DNA binding domain. Nucleic Acid Res 21:1125-1132
12. Kumar V, Chambon P 1988 The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55:145-156
13. Fawell SE, Lees JA, White R, Parker MG 1990 Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell 60:953-962
14. Cowley SM, Hoare S, Mosselman S, Parker MG 1997 Estrogen receptors α and β form heterodimers on DNA. J Biol Chem 272:19858-19862
15. Kato S, Tora L, Yamauchi J, Masushige S, Bellard M, Chambon P 1992 A far upstream estrogen response element of the ovalbumin gene contains several half-palindromic 5′-TGACC-3′ motifs acting synergistically. Cell 68:731-742
16. Vanacker J-M, Petterson K, Gustafsson J-A, Laudet V 1999 Transcriptional targets shared by estrogen receptor-related (ERRs) and estrogen receptor (ER)α, but not ERβ. EMBO J 18:4270-4279
17. Klinge CM 2001 Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 29:2905-2919
18. Klein-Hitpass L, Schorpp M, Wagner U, Ryffel GU 1986 An estrogen-responsive element derived from the 5′ flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell 46:1053-1061
19. Sanchez R, Nguyen D, Rocha W, White JH, Mader S 2002 Diversity in the mechanisms of gene regulation by estrogen receptors. Bioessays 24:244-254
20. Glass CK 1994 Differential recognition of target genes by nuclear receptor monomers, dimers and heterodimers. Endocr Rev 15:391-407
21. Khorasanizadeh S, Rastinejad F 2001 Nuclear-receptor interactions on DNA-response elements. Trends Biochem Sci 26:384-390
22. Chen H, Lin RJ, Xie W, Wilpitz D, Evans RM 1999 Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell 98:675-686
23. Burakov D, Crofts LA, Chang CP, Freedman LP 2002 Reciprocal recruitment of DRIP/mediator and p160 coactivator complexes in vivo by estrogen receptor. J Biol Chem 277:14359-14362
24. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M 2000 Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-852
25. Reid G, Hubner MR, Metivier R, Brand H, Kos M, Gannon F 2003 Cyclic, proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling. Mol Cell 11:695-707
26. Leo C, Chen JD 2000 The SRC family of nuclear receptor coactivators. Gene 245:1-11
27. Robyr D, Wolffe A, Wahli W 2000 Nuclear hormone receptor coregulators in action: diversity for shared tasks. Mol Endocrinol 14:329-346
28. Rosenfeld MG, Glass CK 2001 Coregulator codes of transcriptional regulation by nuclear receptors. J Biol Chem 276:36865-36868
29. Rachez C, Freedman LP 2001 Mediator complexes and transcription. Curr Opin Cell Biol 13:274-280
30. Dilworth FJ, Chambon P 2001 Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription. Oncogene 20:3047-3054
31. McDonnell DP, Norris JD 2002 Connections and regulation of the human estrogen receptor. Science 296:1642-1644
32. Belandia B, Parker MG 2003 Nuclear receptors: a rendezvous for chromatin remodeling factors. Cell 114:277-280
33. Métivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M, Gannon F 2003 Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115:751-763
34. Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uht RM, Webb P 2000 Estrogen receptor pathways and AP-1. J Steroid Biochem Mol Biol 74:311-317
35. Safe S 2001 Transcriptional activation of genes by 17β-estradiol through estrogen receptor-Sp1 interactions. Vitam Horm 62:231-252
36. Kelly MJ, Levin ER 2001 Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab 12:152-156
37. McEwen B, Akama K, Alves S, Brake WG, Bulloch K, Lee S, Li C, Yuen G, Milner TA 2001 Tracking the estrogen receptor in neurons: implications for estrogen-induced synapse formation. Proc Natl Acad Sci USA 98:7093-7100
38. Moggs JG, Orphanides G 2001 Estrogen receptors: orchestrators of pleiotropic cellular responses. EMBO Rep 2:775-781
39. Inoue S, Orimo A, Hosoi T, Kondo S, Toyoshima H, Kondo T, Ikegami A, Ouchi Y, Orimo H, Muramatsu M 1993 Genomic binding-site cloning reveals an estrogen-responsive gene that encodes a RING finger protein. Proc Natl Acad Sci USA 90:11117-11121
40. Watanabe T, Inoue S, Hiroi H, Orimo A, Kawashima H, Muramatsu M 1998 Isolation of estrogen-responsive genes with a CpG island library. Mol Cell Biol 18:442-449
41. Ikeda K, Sato M, Tsutsumi O, Tsuchiya F, Tsuneizumi M, Emi M, Imoto I, Inazawa J, Muramatsu M, Inoue S 2000 Promoter analysis and chromosomal mapping of human EBAG9 gene. Biochem Biophys Res Commun 273:654-660
42. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin JC, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kanne L, Lehoczky J, LeVine R, McEwan P, Mckernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, et al 2001 Initial sequencing and analysis of the human genome. Nature 409:860-921
43. Tsai S-J, Wu M-H, Chen H-M, Chuang P-C, Wing L-YC 2002 Fibroblast growth factor-9 is an endometrial stromal growth factor. Endocrinology 143:2715-2721
44. Cohen RI, Chandross KJ 2000 Fibroblast growth factor-9 modulates the expression of myelin related proteins and multiple fibroblast growth factor receptors in developing oligodendrocytes. J Neurosci Res 61:273-287
45. Colvin JS, Green RP, Schmahl J, Capel B, Ornitz DM 2001 Male-to-female sex reversal in mice lacking fibroblast growth factor 9. Cell 104:875-889
46. Toshima J, Ohashi K, Okano I, Nunoue K, Kishioka M, Kuma K, Miyata T, Hirai M, Baba T, Mizuno K 1995 Identification and characterization of a novel protein kinase, TESK1, specifically expressed in testicular germ cells. J Biol Chem 270:31331-31337
47. Toshima J, Koji T, Mizuno K 1998 Stage-specific expression of testis-specific protein kinase 1 (TESK1) in rat spermatogenic cells. Biochem Biophys Res Commun 249:107-112
48. Venables JP, Vernet C, Chew SL, Elliott DJ, Cowmeadow RB, Wu J, Cooke HJ, Artzt K, Eperon IC 1999 T-STAR/ETOILE: a novel relative of SAM68 that interacts with an RNA-binding protein implicated in spermatogenesis. Hum Mol Genet 8:959-969
49. Valve E, Penttila TL, Paranko J, Harkonen P 1997 FGF-8 is expressed during specific phases of rodent oocyte and spermatogonium development. Biochem Biophys Res Commun 232:173-177
50. Kang HY, Yeh S, Fujimoto N, Chang C 1999 Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor. J Biol Chem 274:8570-8576
51. Couse JE, Mahato D, Eddy EM, Korach KS 2001 Molecular mechanism of estrogen action in the male: insights from the estrogen receptor null mice. Reprod Fertil Dev 13:211-219
52. Murata Y, Robertson KM, Jones ME, Simpson ER 2002 Effect of estrogen deficiency in the male: the ArKO mouse model. Mol Cell Endocrinol 193:7-12
53. Carreau S 2003 Estrogens - male hormones? Folia Histochem Cytobiol 41:107-111
54. Soulez M, Parker MG 2001 Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling. J Mol Endocrinol 27:259-274
55. Mally MI, Cirulli V, Otonkoski T, Soto G, Hayek A 1996 Ontogeny and tissue distribution of human GAD expression. Diabetes 45:496-501
56. McCarthy MM, Kaufman LC, Brooks PJ, Pfaff DW, Schwartz-Giblin S 1995 Estrogen modulation of mRNA levels for the two forms of glutamic acid decarboxylase (GAD) in female rat brain. J Comp Neurol 360:685-697
57. Bosma PT, Blazquez M, Fraser EJ, Schulz RW, Docherty K, Trudeau VL 2001 Sex steroid regulation of glutamate decarboxylase mRNA expression in goldfish brain is sexually dimorphic. J Neurochem 76:945-956
58. Wondisford FE, Radovick S, Moates JM, Usala SJ, Weintraub BD 1988 Isolation and characterization of the human thyrotropin β-subunit gene. Differences in gene structure and promoter function from murine species. J Biol Chem 263:12538-12542
59. Gurr JA, Vrontakis ME, Athanasian EA, Wagner CR, Kourides IA 1986 Hormonal regulation of thyrotropin α and β subunit mRNAs. Horm Metab Res 18:382-385
60. Podvinec M, Kaufmann MR, Handschin C, Meyer UA 2002 NUBIScan, an in silico approach for prediction of nuclear receptor response elements. Mol Endocrinol 16:1269-1279
61. Bajic VB, Tan SL, Chong A, Tang S, Strom A, Gustafsson JA, Lin CY, Liu ET 2003 Dragon ERE Finder version 2: a tool for accurate detection and analysis of estrogen response elements in vertebrate genomes. Nucleic Acids Res 31:3605-3607
62. Iyer VR, Horak CE, Scafe CS, Botstein D, Snyder M, Brown PO 2001 Genomic binding sites of the yeast cell-cycle transcription factors SBF and MBF. Nature 409:533-538
63. Lieb JD, Liu X, Botstein D, Brown PO 2001 Promoter-specific binding of Rap1 revealed by genome-wide maps of protein-DNA association. Nat Genet 28:327-334
64. Topalidou I, Thireos G 2003 Gcn4 occupancy of open reading frame regions results in the recruitment of chromatin-modifying complexes but not the mediator complex. EMBO Rep 4:872-876
65. Martone R, Euskirchen G, Bertone P, Hartman S, Royce TE, Luscombe NM, Rinn JL, Nelson FK, Miller P, Gerstein M, Weissman S, Snyder M 2003 Distribution of NF-κB-binding sites across human chromosome 22. Proc Natl Acad Sci USA 100:12247-12252
66. Toft D, Gorski J 1966 A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization. Proc Natl Acad Sci USA 55:1574-1581
67. Clark JH, Gorski J 1970 Ontogeny of the estrogen receptor during early uterine development. Science 169:76-78
68. Notides AC 1970 The binding affinity and specificity of the estrogen receptor of the rat uterus and anterior pituitary. Endocrinology 87:987-992
69. Stumpf WE, Sar M, Zuber TJ, Soini E, Tuohimaa P 1981 Quantitative assessment of steroid hormone binding sites by thaw-mount autoradiography. J Histochem Cytochem 29:201-206
70. Fernandez PC, Frank SR, Wang L, Schroeder M, Liu S, Greene J, Cocito A, Amati B 2003 Genomic targets of the human c-Myc protein. Genes Dev 17:1115-1129
71. Bhat RA, Harnish DC, Stevis PE, Lyttle CR, Komm BS 1998 A novel human estrogen receptor β: identification and functional analysis of additional N-terminal amino acids. J Steroid Biochem Mol Biol 67:233-240
72. Green S, Issemann I, Sheer E 1988 A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res 16:369
73. Nguyen D, Steinberg SV, Rouault E, Chagnon S, Gottlieb B, Pinsky L, Trifiro M, Mader S 2001 A G577R mutation in the human AR P box results in selective decreases in DNA binding and in partial androgen insensitivity syndrome. Mol Endocrinol 15:1790-1802
74. Agarwal A, Yeung WS, Lee KF 2002 Cloning and characterization of the human oviduct-specific glycoprotein (HuOGP) gene promoter. Mol Hum Reprod 8:167-175
75. Takahashi K, Sendai Y, Matsuda Y, Hoshi H, Hiroi M, Araki Y 2000 Mouse oviduct-specific glycoprotein gene: genomic organization and structure of the 5′-flanking regulatory region. Biol Reprod 62:217-226
76. Zhao YY, Zhou J, Narayanan CS, Cui Y, Kumar A 1999 Role of C/A polymorphism at -20 on the expression of human angiotensinogen gene. Hypertension 33:108-115
77. Congiu M, Clouston WM, Fernley RT, Richards RI 1992 The function of conserved elements in the promoter of the mouse angiotensinogen gene. J Mol Endocrinol 9:19-29
78. Berry M, Nunez A-M, Chambon P 1989 Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc Natl Acad Sci USA 86:1218-1222
79. Richard S, Zingg HH 1990 The human oxytocin promoter is regulated by estrogens. J Biol Chem 265:6098-6103
80. Perillo B, Sasso A, Abbondanza C, Palumbo G 2000 17β-Estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol Cell Biol 20:2890-2901
81. Citarella F, Misiti S, Felici A, Aiuti A, La Porta C, Fantoni A 1993 The 5′ sequence of human Factor XII gene contains transcription regulatory elements typical of liver specific, estrogen-modulated genes. Biochim Biophys Acta 1172:197-199
82. Kyo S, Takakura M, Kanaya T, Zhuo W, Fujmoto K, Nishio Y, Orimo A, Inoue M 1999 Estrogen activates telomerase. Cancer Res 59:5917-5921
83. Fan JD, Wagner BL, McDonnell DP 1996 Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity. Mol Endocrinol 10:1605-1616
84. Augereau P, Miralles F, Cavaillès V, Gaudelet C, Parker M, Rochefort H 1994 Characterization of the proximal estrogen-responsive element of human cathepsin D gene. Mol Endocrinol 8:693-703
85. Teng CT, Liu Y, Yang N, Walmer D, Panella T 1992 Differential molecular mechanism of the estrogen action that regulates lactoferrin gene in human and mouse. Mol Endocrinol 6:1969-1981
86. Lee M, Liu Y, Zhang X 1995 A retinoic acid response element that overlaps an estrogen response element mediates multihormonal sensitivity in transcriptional activation of the lactoferrin gene. Mol Cell Biol 15:4194-4207
87. Lobenhofer EK, Bennett L, Cable PL, Li L, Bushel PR, Afshari CA 2002 Regulation of DNA replication fork genes by 17β-estradiol. Mol Endocrinol 16:1215-1229
88. Revillion F, Pawlowski V, Hornez L, Peyrat JP 2000 Glyceraldehyde-3- phosphate dehydrogenase gene expression in human breast cancer. Eur J Cancer 36:1038-1042
89. Ghosh MG, Thompson DA, Weigel RJ 2000 PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res 60:6367-6375
90. Hashimoto S, Miwa M, Akasofu K, Nishida E 1991 Changes in 40 serum proteins of post-menopausal women. Maturitas 13:23-33
91. Inoue A, Yoshida N, Omoto Y, Oguchi S, Yamori T, Kiyama R, Hayashi S 2002 Development of cDNA microarray for expression profiling of estrogen-responsive genes. J Mol Endocrinol 29:175-192
92. Bhat KP, Pezzuto JM 2001 Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells. Cancer Res 61:6137-6144
93. Apparao KB, Lovely LP, Gui Y, Lininger RA, Lessey BA 2002 Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome. Biol Reprod 66:297-304
94. Pedram A, Razandi M, Aitkenhead M, Hughes CC, Levin ER 2002 Integration of the non-genomic and genomic actions of estrogen. Membrane-initiated signaling by steroid to transcription and cell biology. J Biol Chem 277:50768-50775
95. Charpentier AH, Bednarek AK, Daniel RL, Hawkins KA, Laflin KJ, Gaddis S, MacLeod MC, Aldaz CM 2000 Effects of estrogen on global gene expression: identification of novel targets of estrogen action. Cancer Res 60:5977-5983
96. Xie T, Ho SL, Ramsden D 1999 Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol Pharmacol 56:31-38
97. Seth P, Krop I, Porter D, Polyak K 2002 Novel estrogen and tamoxifen induced genes identified by SAGE (serial analysis of gene expression). Oncogene 21:836-843
98. Zhang SY, Liu SC, Al-Saleem LF, Holloran D, Babb J, Guo X, Klein-Szanto AJ 2000 E2F-1: a proliferative marker of breast neoplasia. Cancer Epidemiol Biomarkers Prev 9:395-401
99. Seo HS, Larsimont D, Querton G, El Khissiin A, Laios N, Legros N, Leclercq G 1998 Estrogenic and anti-estrogenic regulation of estrogen receptor in MCF-7 breast-cancer cells: comparison of immunocytochemical data with biochemical measurements. Int J Cancer 78:760-765
100. Shimomura Y, Matsuo H, Samoto T, Maruo T 1998 Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma. J Clin Endocrinol Metab 83:2192-2198
101. Kuang WW, Thompson DA, Hoch RV, Weigel RJ 1998 Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line. Nucleic Acids Res 26:1116-1123
102. Piotrowicz RS, Ding L, Maher P, Levin EG 2001 Inhibition of cell migration by 24-kDa fibroblast growth factor-2 is dependent upon the estrogen receptor. J Biol Chem 276:3963-3970
103. Kumar P, Mark PJ, Ward BK, Minchin RF, Ratajczak T 2001 Estradiol-regulated expression of the immunophilins cyclophilin 40 and FKBP52 in MCF-7 breast cancer cells. Biochem Biophys Res Commun 284:219-225
104. Duan R, Porter W, Safe S, Weisz A, Rosales R 1998 Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation. Endocrinology 139:1981-1990
105. Daly RJ, Gu H, Parmar J, Malaney S, Lyons RJ, Kairouz R, Head DR, Henshall SM, Neel BG, Sutherland RL 2002 The docking protein Gab2 is overexpressed and estrogen regulated in human breast cancer. Oncogene 21:5175-5181
106. Ormandy CJ, Lee CS, Ormandy HF, Fantl V, Shine J, Peters G, Sutherland RL 1998 Amplification, expression, and steroid regulation of the preprogalanin gene in human breast cancer. Cancer Res 58:1353-1357
107. Kang SK, Choi KC, Tai CJ, Auersperg N, Leung PC 2001 Estradiol regulates gonadotropin-releasing hormone (GnRH) and its receptor gene expression and antagonizes the growth inhibitory effects of GnRH in human ovarian surface epithelial and ovarian cancer cells. Endocrinology 142:580-588
108. Inadera H, Hashimoto S, Dong HY, Suzuki T, Nagai S, Yamashita T, Toyoda N, Matsushima K 2000 WISP-2 as a novel estrogen-responsive gene in human breast cancer cells. Biochem Biophys Res Commun 275:108-114
109. Tschugguel W, Stonek F, Zhegu Z, Dietrich W, Schneeberger C, Stimpfl T, Waldhoer T, Vycudilik W, Huber JC 2001 Estrogen increases endothelial carbon monoxide, heme oxygenase 2, and carbon monoxide-derived cGMP by a receptor-mediated system. J Clin Endocrinol Metab 86:3833-3839
110. Lee AV, Jackson JG, Gooch JL, Hilsenbeck SG, Coronado-Heinsohn E, Osborne CK, Yee D 1999 Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol Endocrinol 13:787-796
111. Molloy CA, May FE, Westley BR 2000 Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line. J Biol Chem 275:12565-12571
112. Mauro L, Salerno M, Panno ML, Bellizzi D, Sisci D, Miglietta A, Surmacz E, Ando S 2001 Estradiol increases IRS-1 gene expression and insulin signaling in breast cancer cells. Biochem Biophys Res Commun 288:685-689
113. Oesterreich S, Zhang P, Guler RL, Sun X, Curran EM, Welshons WV, Osborne CK, Lee AV 2001 Re-expression of estrogen receptor α in estrogen receptor α-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth. Cancer Res 61:5771-5777
114. Pentecost BT 1998 Expression and estrogen regulation of the HEM45 MRNA in human tumor lines and in the rat uterus. J Steroid Biochem Mol Biol 64:25-33
115. Choi I, Gudas LJ, Katzenellenbogen BS 2000 Regulation of keratin 19 gene expression by estrogen in human breast cancer cells and identification of the estrogen responsive gene region. Mol Cell Endocrinol 164:225-237
116. Seth P, Porter D, Lahti-Domenici J, Geng Y, Richardson A, Polyak K 2002 Cellular and molecular targets of estrogen in normal human breast tissue. Cancer Res 62:4540-4544
117. Moalli PA, Klingensmith WL, Meyn LA, Zyczynski HM 2002 Regulation of matrix metalloproteinase expression by estrogen in fibroblasts that are derived from the pelvic floor. Am J Obstet Gynecol 187:72-79
118. Harendza S, Lovett DH, Panzer U, Lukacs Z, Kuhnl P, Stahl RA 2003 Linked common polymorphisms in the gelatinase a promoter are associated with diminished transcriptional response to estrogen and genetic fitness. J Biol Chem 278:20490-20499
119. Marin-Castano ME, Elliot SJ, Potier M, Karl M, Striker LJ, Striker GE, Csaky KG, Cousins SW 2003 Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium. Invest Ophthalmol Vis Sci 44:50-59
120. Kleinert H, Wallerath T, Euchenhofer C, Ihrig-Biedert I, Li H, Forstermann U 1998 Estrogens increase transcription of the human endothelial NO synthase gene: analysis of the transcription factors involved. Hypertension 31:582-588
121. Skaar TC, Prasad SC, Sharareh S, Lippman ME, Brunner N, Clarke R 1998 Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen-independence in human breast cancer cells. J Steroid Biochem Mol Biol 67:391-402
122. Prange-Kiel J, Rune GM, Zwirner M, Wallwiener D, Kiesel L 2001 Regulation of estrogen receptor α and progesterone receptor (isoform A and B) expression in cultured human endometrial cells. Exp Clin Endocrinol Diabetes 109:231-237
123. Martini PG, Katzenellenbogen BS 2001 Regulation of prothymosin α gene expression by estrogen in estrogen receptor-containing breast cancer cells via upstream half-palindromic estrogen response element motifs. Endocrinology 142:3493-3501
124. Wang Z, Kyo S, Maida Y, Takakura M, Tanaka M, Yatabe N, Kanaya T, Nakamura M, Koike K, Hisamoto K, Ohmichi M, Inoue M 2002 Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells. Oncogene 21:3517-3524
125. Gruvberger S, Ringner M, Chen Y, Panavally S, Saal LH, Borg A, Ferno M, Peterson C, Meltzer PS 2001 Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res 61:5979-5984
126. Qin C, Nguyen T, Stewart J, Samudio I, Burghardt R, Safe S 2002 Estrogen up-regulation of p53 gene expression in MCF-7 breast cancer cells is mediated by calmodulin kinase IV-dependent activation of a nuclear factor κB/CCAAT-binding transcription factor-1 complex. Mol Endocrinol 16:1793-1809
127. Duque G, Abdaimi KE, Macoritto M, Miller MM, Kremer R 2002 Estrogens (E2) regulate expression and response of 1,25-dihydroxyvitamin D3 receptors in bone cells: changes with aging and hormone deprivation. Biochem Biophys Res Commun 299:446-454
128. Katoh M 2003 Expression and regulation of WNT1 in human cancer: up-regulation of WNT1 by β-estradiol in MCF-7 cells. Int J Oncol 22:209-212
129. Kirikoshi H, Katoh M 2002 Expression and regulation of WNT10B in human cancer: up-regulation of WNT10B in MCF-7 cells by β-estradiol and down-regulation of WNT10B in NT2 cells by retinoic acid. Int J Mol Med 10:507-511
130. Kirikoshi H, Sekihara H, Katoh M 2001 Expression of WNT14 and WNT14B mRNAs in human cancer, up-regulation of WNT14 by IFNγ and up-regulation of WNT14B by β-estradiol. Int J Oncol 19:1221-1225
131. Levenson AS, Svoboda KM, Pease KM, Kaiser SA, Chen B, Simons LA, Jovanovic BD, Dyck PA, Jordan VC 2002 Gene expression profiles with activation of the estrogen receptor α-selective estrogen receptor modulator complex in breast cancer cells expressing wildtype estrogen receptor. Cancer Res 62:4419-4426
132. Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR, Katzenellenbogen BS 2003 Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144:4562-4574
133. Monroe DG, Getz BJ, Johnsen SA, Riggs BL, Khosla S, Spelsberg TC 2003 Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERα or ERβ. J Cell Biochem 90:315-326
134. Tang S, Han H, Bajic VB 2004 ERGDB: estrogen responsive genes database. Nucleic Acids Res 32:D533-D536